April 14, 2014 — The Therapeutic Goods Administration (TGA), Australia’s largest health regulatory agency, has issued yet another Safety Alert for the Medtronic Paradigm insulin pump.
Several people have been injured by over-delivery or under-delivery of insulin due to various defects in the last few years. TGA has received a number of reports of hypoglycemia (low insulin), including one person who was hospitalized.
The insulin pump can deliver continuous, minimal doses of insulin (basal) or single large doses when required (bolus). The problem is that the click of a button can switch the pump from zero to maximum in certain modes.
The Medtronic Paradigm Insulin Pump has been the subject of several warnings in the last few years. U.S. Food and Drug Administration (FDA) previously issued a Class 1 Recall for Paradigm Insulin pumps in July 2013.
In addition, the TGA published a Safety Advisory in April 2013 for three defects that they said were unlikely to cause serious injury. However, in one case, a patient tried to push the drive support cap into position and accidentally gave themselves a large dose of insulin, which resulted in hypoglycemia (low blood-sugar levels).
Do I have a Medtronic Paradigm Insulin Pump Lawsuit?
The Schmidt Firm, PLLC is currently accepting Medtronic Paradigm insulin pump induced injury cases in all 50 states. If you or somebody you know has been injured, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Medical Device Litigation Group or call toll free 24 hours a day at (866) 920-0753.
Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.